Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Mireille Mouroux

Polymorphism of the Human Immunodeficiency Virus Type 1 (HIV-1) Protease Gene and Response of HIV-1-Infected Patients to a Protease Inhibitor

Journal of Clinical Microbiology

Microbiology

1999

English

Related publications

Intracellular Expression of Human Immunodeficiency Virus Type 1 (HIV-1) Protease Variants Inhibits Replication of Wild-Type and Protease Inhibitor-Resistant HIV-1 Strains in Human T-Cell Lines.

English

Activities of the Human Immunodeficiency Virus Type 1 (HIV-1) Protease Inhibitor Nelfinavir Mesylate in Combination With Reverse Transcriptase and Protease Inhibitors Against Acute HIV-1 Infection in Vitro.

Antimicrobial Agents and Chemotherapy

Infectious Diseases

Pharmacology

1997

English

Crystal Structure of Human Immunodeficiency Virus (HIV) Type 2 Protease in Complex With a Reduced Amide Inhibitor and Comparison With HIV-1 Protease Structures.

Proceedings of the National Academy of Sciences of the United States of America

Multidisciplinary

1993

English

Safety and Pharmacokinetics of Amprenavir (141W94), a Human Immunodeficiency Virus (HIV) Type 1 Protease Inhibitor, Following Oral Administration of Single Doses to HIV-Infected Adults

Antimicrobial Agents and Chemotherapy

Infectious Diseases

Pharmacology

1999

English

Defining the Level of Human Immunodeficiency Virus Type 1 (HIV-1) Protease Activity Required for HIV-1 Particle Maturation and Infectivity.

English

Variant Human Immunodeficiency Virus Type 1 Proteases and Response to Combination Therapy Including a Protease Inhibitor

Antimicrobial Agents and Chemotherapy

Infectious Diseases

Pharmacology

2001

English

In Vitro Selection and Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Isolates With Reduced Sensitivity to Hydroxyethylamino Sulfonamide Inhibitors of HIV-1 Aspartyl Protease.

English

Robust Growth of Human Immunodeficiency Virus Type 1 (HIV-1)

Biophysical Journal

Biophysics

2005

English

Mutation Patterns and Structural Correlates in Human Immunodeficiency Virus Type 1 Protease Following Different Protease Inhibitor Treatments

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Mireille Mouroux

Polymorphism of the Human Immunodeficiency Virus Type 1 (HIV-1) Protease Gene and Response of HIV-1-Infected Patients to a Protease Inhibitor

Related publications

Intracellular Expression of Human Immunodeficiency Virus Type 1 (HIV-1) Protease Variants Inhibits Replication of Wild-Type and Protease Inhibitor-Resistant HIV-1 Strains in Human T-Cell Lines.

Activities of the Human Immunodeficiency Virus Type 1 (HIV-1) Protease Inhibitor Nelfinavir Mesylate in Combination With Reverse Transcriptase and Protease Inhibitors Against Acute HIV-1 Infection in Vitro.

Crystal Structure of Human Immunodeficiency Virus (HIV) Type 2 Protease in Complex With a Reduced Amide Inhibitor and Comparison With HIV-1 Protease Structures.

Safety and Pharmacokinetics of Amprenavir (141W94), a Human Immunodeficiency Virus (HIV) Type 1 Protease Inhibitor, Following Oral Administration of Single Doses to HIV-Infected Adults

Defining the Level of Human Immunodeficiency Virus Type 1 (HIV-1) Protease Activity Required for HIV-1 Particle Maturation and Infectivity.

Variant Human Immunodeficiency Virus Type 1 Proteases and Response to Combination Therapy Including a Protease Inhibitor

In Vitro Selection and Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Isolates With Reduced Sensitivity to Hydroxyethylamino Sulfonamide Inhibitors of HIV-1 Aspartyl Protease.

Robust Growth of Human Immunodeficiency Virus Type 1 (HIV-1)

Mutation Patterns and Structural Correlates in Human Immunodeficiency Virus Type 1 Protease Following Different Protease Inhibitor Treatments